BioCentury
ARTICLE | Company News

Argyle Therapeutics, Brickell Biotech Inc deal

April 23, 2012 7:00 AM UTC

Argyle granted Brickell exclusive, worldwide rights to develop and commercialize SIG990 for dermatology indications. Argyle is eligible for milestones and royalties. The topical anti-inflammatory sma...